NASDAQ
THTX

Theratechnologies Inc.

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Theratechnologies Inc. Stock Price

Vitals

Today's Low:
$1.8600
Today's High:
$1.9461
Open Price:
$1.9461
52W Low:
$1.78
52W High:
$3.65
Prev. Close:
$1.9100
Volume:
38356

Company Statistics

Market Cap.:
$0.180 billion
Book Value:
0.187
Revenue TTM:
$0.077 billion
Operating Margin TTM:
-46.4%
Gross Profit TTM:
$0.051 billion
Gross Profit TTM:
$0.051 billion
Profit Margin:
-63.6%
Return on Assets TTM:
-20.1%
Return on Equity TTM:
-1117%

Company Profile

Theratechnologies Inc. had its IPO on 2016-01-04 under the ticker symbol THTX.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Theratechnologies Inc. has a staff strength of 0 employees.

Stock update

Shares of Theratechnologies Inc. opened at $1.95 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $1.86 - $1.95, and closed at $1.89.

This is a -1.05% slip from the previous day's closing price.

A total volume of 38,356 shares were traded at the close of the day’s session.

In the last one week, shares of Theratechnologies Inc. have slipped by -5.5%.

Theratechnologies Inc.'s Key Ratios

Theratechnologies Inc. has a market cap of $0.180 billion, indicating a price to book ratio of 20.13 and a price to sales ratio of 2.324.

In the last 12-months Theratechnologies Inc.’s revenue was $0.077 billion with a gross profit of $0.051 billion and an EBITDA of $-0.023 billion. The EBITDA ratio measures Theratechnologies Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Theratechnologies Inc.’s operating margin was -46.4% while its return on assets stood at -20.1% with a return of equity of -1117%.

In Q2.6666666666667, Theratechnologies Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 16.6%.

Theratechnologies Inc.’s PE and PEG Ratio

Forward PE
55.87
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-0.367 per share while it has a forward price to earnings multiple of 55.87 and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Theratechnologies Inc.’s profitability.

Theratechnologies Inc. stock is trading at a EV to sales ratio of 2.735 and a EV to EBITDA ratio of -7.16. Its price to sales ratio in the trailing 12-months stood at 2.324.

Theratechnologies Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Theratechnologies Inc. ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Theratechnologies Inc. ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Theratechnologies Inc.’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Theratechnologies Inc.'s operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Theratechnologies Inc. paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$1.89
52-Week High
$3.65
52-Week Low
$1.78
Analyst Target Price
$4.6

Theratechnologies Inc. stock is currently trading at $1.89 per share. It touched a 52-week high of $3.65 and a 52-week low of $3.65. Analysts tracking the stock have a 12-month average target price of $4.6.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Theratechnologies Inc.

The stock symbol (also called stock or share ticker) of Theratechnologies Inc. is THTX

The IPO of Theratechnologies Inc. took place on 2016-01-04

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
Alkermes Plc (ALKS)
$24.06
0.81
+3.48%
$10.31
-0.33
-3.1%
$12.97
-0.23
-1.71%
$15.93
0.07
+0.44%
$253.65
25.26
+11.06%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Theratechnologies Inc., a biopharmaceutical company, is focused on the development and commercialization of various therapies to address unmet medical needs in the United States, Canada, and Europe. The company is headquartered in Montreal, Canada.

Address

2015 PEEL STREET, 5TH FLOOR, MONTREAL, QC, CA